Effect of phentolamine methanesulfonate upon uterine contractility induced by 1-norepinephrine pregnancy.
D000653:Amniotic Fluid / Q000502:physiology; D000814:Aniline Compounds / Q000494:pharmacology*; D001565:Benzoates / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects; D002082:Butylamines / Q000494:pharmacology*; D005260:Female; D005318:Fetal Heart / Q000187:drug effects; D006801:Humans; D007263:Infusions, Parenteral; D007275:Injections, Intravenous; D007751:Labor, Induced; D009119:Muscle Contraction / Q000187:drug effects; D009638:Norepinephrine / Q000008:administration & dosage / Q000494:pharmacology*; D010646:Phentolamine / Q000494:pharmacology*; D011247:Pregnancy; D011674:Pulse / Q000187:drug effects; D011984:Sensory Receptor Cells / Q000187:drug effects; D013451:Sulfonic Acids / Q000494:pharmacology*; D014599:Uterus / Q000187:drug effects*
D000814:Aniline Compounds; D001565:Benzoates; D002082:Butylamines; D013451:Sulfonic Acids; D009638:Norepinephrine; D010646:Phentolamine